MUSELLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.624
AS - Asia 1.206
EU - Europa 220
SA - Sud America 42
Continente sconosciuto - Info sul continente non disponibili 30
AF - Africa 21
OC - Oceania 5
Totale 3.148
Nazione #
US - Stati Uniti d'America 1.378
TR - Turchia 472
CN - Cina 354
SG - Singapore 313
CA - Canada 240
IT - Italia 119
BR - Brasile 34
DE - Germania 31
EU - Europa 28
HK - Hong Kong 26
SC - Seychelles 13
IE - Irlanda 11
RU - Federazione Russa 10
SE - Svezia 10
GB - Regno Unito 9
IN - India 9
BD - Bangladesh 7
JP - Giappone 6
NL - Olanda 5
AU - Australia 4
CH - Svizzera 4
FI - Finlandia 4
PL - Polonia 4
MX - Messico 3
RO - Romania 3
UA - Ucraina 3
UZ - Uzbekistan 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BO - Bolivia 2
CO - Colombia 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
NP - Nepal 2
PK - Pakistan 2
ZA - Sudafrica 2
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
EC - Ecuador 1
FR - Francia 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
MA - Marocco 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.148
Città #
San Mateo 448
Kocaeli 401
Toronto 225
Wilmington 113
Santa Clara 101
Singapore 100
Houston 83
Lawrence 78
Princeton 78
Beijing 65
Chandler 54
Ashburn 45
Shanghai 41
Rome 36
Los Angeles 31
Hong Kong 24
Guangzhou 23
The Dalles 19
Fairfield 18
Seattle 18
Woodbridge 16
Columbus 15
Shenzhen 14
West Jordan 10
Dallas 9
Falls Church 9
Cambridge 8
Jiaxing 7
Milan 7
Rui'an 6
Wuxi 6
Boston 5
Brooklyn 5
Stockholm 5
Viggiù 5
Xi'an 5
Council Bluffs 4
Florence 4
Helsinki 4
Montreal 4
Palermo 4
Redwood City 4
São Paulo 4
Tokyo 4
Wuhan 4
Atlanta 3
Belo Horizonte 3
Bern 3
Boardman 3
Chicago 3
Dongyang 3
Kemerovo 3
Lariano 3
Munich 3
Phoenix 3
Pune 3
San Francisco 3
Taizhou 3
Warsaw 3
Xuzhou 3
Al Qahirah al Jadidah 2
Alessandria 2
Amsterdam 2
Andover 2
Bengbu 2
Berlin 2
Brampton 2
Chengdu 2
Chennai 2
Città di Castello 2
Dhaka 2
Dublin 2
Hobart 2
Jinan 2
Las Vegas 2
London 2
Mexico City 2
Moscow 2
Nanchang 2
New York 2
Pistoia 2
Salt Lake City 2
Secaucus 2
Tashkent 2
Turin 2
Washington 2
Abano Terme 1
Ahmedabad 1
Aimogasta 1
Albany 1
Amman 1
Ankara 1
Antakya 1
Aracaju 1
As Samawah 1
Auckland 1
Basra 1
Basti 1
Bauru 1
Betim 1
Totale 2.280
Nome #
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity 62
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 61
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 61
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 59
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 55
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 53
Linking synaptopathy and gray matter damage in multiple sclerosis 52
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis 52
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 51
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 50
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 50
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 49
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 49
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 49
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis 48
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum 48
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 47
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 46
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 46
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 46
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli 45
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 45
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis 44
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 43
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 43
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 42
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 42
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 42
Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin 42
Obesity worsens central inflammation and disability in multiple sclerosis 42
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 41
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 41
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 41
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 41
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 40
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 40
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 40
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis 39
Adaptations of striatal endocannabinoid system during stress 39
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 38
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 38
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 38
TRPV1 channels facilitate glutamate transmission in the striatum 38
MiR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation 38
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 37
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 37
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 37
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 36
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum 36
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 36
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 36
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 36
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 36
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 35
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 34
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 34
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study 33
Cerebellar control of cortico-striatal LTD 33
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 33
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 32
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 32
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage 32
Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission 32
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 31
Interleukin-1β causes anxiety by interacting with the endocannabinoid system 30
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis 30
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 30
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 30
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 28
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 28
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 28
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 28
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 28
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 27
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 24
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 22
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 21
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 19
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 18
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 17
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 17
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 16
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 16
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 15
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 14
Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis 12
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 11
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 11
Electrophysiology of Endocannabinoid Signaling 11
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 10
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 10
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 10
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity 9
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 9
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 8
Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases 8
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients 8
Totale 3.307
Categoria #
all - tutte 37.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021650 48 34 5 1 27 25 33 9 16 13 403 36
2021/2022871 2 222 232 4 6 8 34 92 20 226 19 6
2022/2023306 179 4 4 19 8 14 0 9 10 19 23 17
2023/2024226 4 6 8 41 6 14 1 12 0 37 0 97
2024/20251.002 50 160 103 56 37 145 65 48 145 22 39 132
2025/202667 67 0 0 0 0 0 0 0 0 0 0 0
Totale 3.307